684 results on '"Warner, Timothy D"'
Search Results
2. Immature platelet dynamics are associated with clinical outcomes after major trauma
3. Factors that modulate platelet reactivity as measured by 5 assay platforms in 3429 individuals
4. Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and Man
5. Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay
6. Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAs
7. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia
8. Proteome and functional decline as platelets age in the circulation
9. Factors which modulate platelet reactivity as measured by five assay platforms in 3,429 individuals
10. Combination of cyclic nucleotide modulators with P2Y12 receptor antagonists as anti‐platelet therapy
11. Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC a randomised controlled trial
12. Multi-parameter phenotyping of platelets and characterisation of the effects of agonists using machine learning
13. Immature platelet dynamics are associated with clinical outcomes after major trauma
14. Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage
15. Assessing Outside the Bubble: Performance Assessment for Common Core State Standards
16. Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity
17. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane [A.sub.2]
18. Role of Toll-Like Receptors 2 and 4 in the Induction of Cyclooxygenase-2 in Vascular Smooth Muscle
19. Expression and Activation of the Farnesoid X Receptor in the Vasculature
20. What can we learn from senescent platelets, their transcriptomes and proteomes?
21. Nonsteroid Drug Selectivities for Cyclo-Oxygenase-1 Rather than Cyclo-Oxygenase-2 Are Associated with Human Gastrointestinal Toxicity: A Full in vitro Analysis
22. Data from The Farnesoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression
23. Supplementary Figures 1-4 from The Farnesoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression
24. Renal function underpins the cyclooxygenase-2: ADMA axis in mouse and man
25. Human Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A3, a Neutrophil-activating Eicosanoid
26. Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin Paradox
27. SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity
28. Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction
29. Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation
30. Platelet ageing: A review
31. Nonsteroidal Antiinflammatory Drugs Inhibiting Prostanoid Efflux: As Easy as ABC?
32. Oral Presentation No. 093 Assessing different noncoding RNAs as markers of platelet reactivity
33. Cyclooxygenase-3 (COX-3): Filling in the Gaps toward a COX Continuum?
34. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay
35. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A2 Proves Renal Origins of Urinary PGI-M and TX-M
36. Abstract 19935: MicroRNA-21 Regulates Transforming Growth Factor Beta-1 Release From Platelets: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition
37. Abstract 18520: Novel Tissue-specific Cyclooxygenase-1 Knockout Mice Demonstrate a Dominant Role for Endothelial Cyclooxygenase-1 in Prostacyclin Production
38. The molecular and biological basis for COX-2 selectivity
39. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition
40. Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia
41. Blockade of the purinergic P2Y₁₂ receptor greatly increases the platelet inhibitory actions of nitric oxide
42. Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAs
43. Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies
44. Nitric oxide and endothelin-1 in circulatory shock involving cytokines
45. Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system
46. Trapping of palindromic ligands within native transthyretin prevents amyloid formation
47. The Development of Specific Endothelin-Receptor Antagonists
48. Endothelin Receptors and Ligands
49. Cytokine Regulation of Endothelin Action
50. Endothelins: Recent Progress
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.